Cystic fibrosis and pregnancy

Area of Science:

• Medical Science
• Pulmonology
• Obstetrics

Background:

• Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs, including the lungs.
• Pregnancy in women with chronic conditions like CF presents unique challenges.
• Understanding the impact of pregnancy on CF patients' health is crucial for management.

Purpose of the Study:

• To assess changes in spirometry and body mass index (BMI) during pregnancy in women with CF.
• To evaluate maternal and neonatal complications and outcomes in CF pregnancies.
• To provide recommendations for planning and managing pregnancies in women with CF.

Main Methods:

• Retrospective review of case records for 11 women with CF who completed 13 pregnancies (1975-1995).
• Analysis of spirometry (FEV1, FVC) and BMI changes pre-pregnancy, during pregnancy, and postpartum.
• Assessment of maternal and neonatal complications, including gestational diabetes, delivery type, and infant outcomes.

Main Results:

• Significant decline in forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) during pregnancy.
• Significant increase in weight and BMI at delivery, returning to pre-pregnancy levels postpartum.
• Mothers with pre-pregnancy FEV1 >80% experienced less spirometry decline, fewer complications, and better outcomes.

Conclusions:

• Pregnancy leads to significant, though often reversible, physiological changes in women with CF.
• Pre-pregnancy lung function is a key predictor of pregnancy outcomes in CF patients.
• Careful planning and management are essential for successful pregnancies in women with CF.